Immunobiologic agents and drugs available from the Centers for Disease Control. Atlanta, GA: Department of Health and Human Services, Public Health Service, Centers for Disease Control, 1987.
2.
Drug facts and comparisons. Philadelphia: JB Lippincott, 1989.
3.
McEvoyGK, ed. American hospital formulary service drug information 88. Bethesda, MD: American Society of Hospital Pharmacists, 1988.
4.
New drug, antibiotic, and biologic drug product regulations; final rule. Fed Regist1987; 52 (March 19): 8798–847.
5.
The United States pharmacopeia XXI, and the national formulary XVI. Rockville, MD: United States Pharmacopeial Convention, 1985: 131, 345, 963, 1112.
6.
Package insert. Botulism antitoxin trivalent (equine), types A, B, and E. Ontario, Canada: Connaught Laboratories, 1977.
GoldsteinJANeffJMLaneJM. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Smallpox eradication program publication. Atlanta, GA: Centers for Disease Control, 1972.
9.
Product information. Western equine encephalitis immune globulin. Atlanta, GA: CDC Drug Service, 1977: 1.
10.
FiockMACarnellaMAGearingerNF. Studies on immunity to toxins of Clostridium botulinum. IX. Immunologic responses of man to purified pentavalent ABCDE botulinum toxoid. J Immunol1963; 90: 697–702.
11.
Biosafety in microbiological and biomedical laboratories. 2nd ed.Washington, DC: US Government Printing Office, 1988.
12.
MonathTPMcCanceCRCravenRB. Japanese encephalitis with specific reference to the low risk for travelers to the 1988 Olympics to be held in Korea. Atlanta, GA: Centers for Disease Control, 1988; CDC advisory memorandum no. 93.
13.
WHO smallpox vaccination certificates. Wkly Epidemiol Rec1981; 56: 305.
14.
International notes: Smallpox vaccination. MMWR1983; 32: 159.
15.
Recommendation of the Immunization Practices Advisory Committee (ACIP). Smallpox vaccine. MMWR1980; 29: 35.
16.
BenjapongWNaeypatimanondSBenjapongK. Studies on paragonimiasis: Treatment with mebendazole, emetine with mebendazole and praziquantel. Southeast Asian J Trop Med Public Health1984; 15: 454–9.
17.
SchiappacasseRHMohammadiDChristieAJ. Successful treatment of severe infection with Fasciola hepatica with praziquantel. J Infect Dis1985; 152: 1339–40.
18.
LoscherT. Praziquantel bei Parasitosen. Münch Med Wochenschr1982; 124: 718.
19.
LangW. Praziquantel (embay 8440) in the therapy of clonorchiasis (abstract). Proceedings of the 10th International Congress on Tropical Medicine and Malaria, 1980; 309: 191.
20.
Product information. Bithionol. Atlanta, GA: CDC Drug Service, 1986: 1–18.
21.
WebsterLT. Drugs used in the chemotherapy of protozoal infections. In: GilmanAGGoodmanLSRallTWMuradF, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed.New York: Macmillan, 1985: 1044, 1051.
22.
HarriesJ. Amoebiasis: A review. J R Soc Med1982; 75: 190–7.
23.
YangWCTDubickM. Mechanism of emetine cardiotoxicity. Pharmacol Ther1980; 10: 15–26.
24.
MainPTBristonNWOxleyP. Entamide. Ann Biochem Exp Med1960; 20: 441–8.
25.
WoodruffAWBellS. Clinical trials with entamide furoate and related compounds. I. In a non-tropical environment. Trans R Soc Trop Med Hyg1960; 54: 389–95.
MarsdenPD. Clinical trials with entamide furoate, entamide piperazine sulphate, and emetine bismuth iodine. II. In a tropical environment. Trans R Soc Trop Med Hyg1960; 54: 396–9.
28.
WoodruffAWBellS. The evaluation of amoebicides. Trans R Soc Trop Med Hyg1967; 61: 435–9.
29.
WilliamsGAH. Experimental hepatic amoebiasis and its application to chemotherapeutic studies. Br J Pharmacol1959; 14: 488–92.
30.
PowellSJStewart-WynneEJElsdon-DewR. Metronidazole combined with diloxanide furoate in amoebic liver abscess. Ann Trop Med Parasitol1973; 67: 367–8.
31.
CampbellWC. Ivermectin: An update. Parasitol Today1985; 1: 10–6.
32.
ScharlauG. Onchocerciasis chemotherapy: A risk approach. Trop Doctor1981; 11: 8–14.
33.
GreenBMTaylorHRCuppEW. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med1985; 313: 133–8.
34.
AwadziKDadzieYSculz-KeyH. The chemotherapy of onchocerciasis. X. An assessment of four single dose treatment regimens of ivermectin in human onchocerciasis. Ann Trop Med Parasitol1982; 79: 63–78.
35.
FriedheimEA. Mel B in the treatment of human trypanosomiasis. Am J Trop Med Hyg1949; 29: 173–80.
36.
LugonesHS. Tratamiento de la enfermedad aguda, eperiencia en Santiago del estero (Argentina). Proceedings of the Simposio Internacional Sobre Enfermedad de Chagas. Buenos Aires, Argentina: Sociedad Argentina de Parasitologia, 1972: 255–9.
37.
FerreiraHDORassEA. Tratamento da fase aguda da doenca de Chagas. Proceedings of the Simposio Internacional Sobre Enfermedad de Chagas. Buenos Aires, Argentina: Sociedad Argentina de Parasitologia, 1972: 261–9.
38.
CerisolaJALugonesHRabinovichLB. Tratamiento de la enfermedad de Chagas. Proceeding of the 60th Premio Cientifico “F. Antonio Rizzuto,”Buenos Aires, Argentina, 1972: 38–46.
39.
Product information. Nifurtimox. Atlanta, GA: CDC Drug Service, 1987: 1–11.
40.
CahillK. The human trypanosomatidae. IV. Cutaneous and mucocutaneous leishmaniasis. NY State J Med1963; 63: 3549.
41.
EmslieE. South American leishmaniasis in London. Br Med J1962; i: 299.
42.
FindlayG. Recent advances in chemotherapy. Vol. I. 3rd ed.Philadelphia: Blakiston1950: 289.
43.
O'BrienRJLyleMASniderDE. Rifabutin (ansamycin LM-427): A new rifamycin-s derivative for the treatment of mycobacterial diseases. Rev Infect Dis1987; 9: 519–30.
44.
SchnitzerRHawkingF. Experimental chemotherapy. Vol. I. London: Academic Press, 1963: 166.
45.
WHO Expert Committee on Trypanosomiasis. First report, technical report series #247. Geneva: World Health Organization, 1962.
46.
MacleanGFairbainH. Treatment of rhodesian sleeping sickness with bayer 205 and tryparsamido; observations on 719 cases. Ann Trop Med Parasitol1932; 26: 157.
47.
Van HoofLHenradCPeelE. The chemotherapy of onchocercosis: Preliminary note. Ann Soc Belg Med Trop1947; 27: 173.
48.
Product information. Suramin. Atlanta, GA: CDC Drug Service, 1978: 5.
49.
WHO Expert Committee on Onchocerciasis. Technical report series #335. Geneva: World Health Organization, 1966.
50.
FainA. Toxic reactions after a single injection of bayer 205 given for prevention of trypanosomiasis. Rev Soc Med Cong Belge1942; 1: 137.
51.
ChestermanC. The therapeutic effect of bayer 205 in trypanosomiasis of the central nervous system. Trans R Soc Trop Med Hyg1924; 18: 311.